Tool: DupCheckTool: DupCheck is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.

Project FlyerProject Flyer

Click here to download 
the NEWMEDS project flyer! 

consortium teaser

Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms

IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

Funding Mechanisms

The European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) share responsibility for the operation and the implementation of the Innovative Medicine Initiative (IMI). The legal entity to do this is the, so-called, IMI Joint Undertaking (IMI-JU) with its Governing Board, its Scientific Committee and its Executive Director (and offices), the latter issuing the calls for research activities and signing the Grant Agreement with the coordinating institution. 
Whereas academic participants and SMEs in an IMI project are funded by the 7th Research Framework Programme, the industrial partners - that have to be EFPIA members - contribute their own funds, matching the amount of public spending at at least a 100%. 

For more information on this new funding mechanisms and the calls please consult the IMI Web Site:


Funding Mechanisms